Patent: 10,039,758
✉ Email this page to a colleague
Summary for Patent: 10,039,758
Title: | Compositions and methods for inhibiting bacterial and viral pathogens |
Abstract: | Compositions and methods including Amodiaquine (AQ) or N-Desethy Amodiaquine (DEAQ) are provided for treating, inhibiting, or preventing cathepsin B dependent pathogens and toxins in a host cell or infected subject. Compositions and methods also include AQ or DEAQ in combination with an antibiotic for more effective clearance of the pathogen and/or toxins. |
Inventor(s): | Martchenko; Mikhail (Claremont, CA), Zilbermintz; Leeor (Encino, CA), Leonardi; William (Rosemead, CA) |
Assignee: | Keck Graduate Institute of Applied Life Sciences (Claremont, CA) |
Application Number: | 14/922,114 |
Patent Claims: | see list of patent claims |
Details for Patent 10,039,758
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Emergent Biodefense Operations Lansing Llc | BIOTHRAX | anthrax vaccine adsorbed | Injection | 103821 | 11/12/1998 | ⤷ Try a Trial | 2034-10-24 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |